Free Trial

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up - Here's Why

Telix Pharmaceuticals Limited American Depositary Shares logo with Medical background
Remove Ads

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX - Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $17.60, but opened at $18.66. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $17.76, with a volume of 7,747 shares changing hands.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on TLX shares. UBS Group upped their price objective on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. William Blair reaffirmed an "outperform" rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Wednesday, March 12th.

Get Our Latest Research Report on TLX

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The company's 50-day moving average is $17.70.

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

(Get Free Report)

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.

Featured Stories

Should You Invest $1,000 in Telix Pharmaceuticals Limited American Depositary Shares Right Now?

Before you consider Telix Pharmaceuticals Limited American Depositary Shares, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Telix Pharmaceuticals Limited American Depositary Shares wasn't on the list.

While Telix Pharmaceuticals Limited American Depositary Shares currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Quantum Stocks Are Heating Up Again — 7 to Watch Now

Quantum Stocks Are Heating Up Again — 7 to Watch Now

After a brief dip earlier this year, fresh momentum has reignited interest; from penny plays to tech giants, these quantum stocks could lead the next surge.

Related Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads